Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS vs GnRH Antagonists in DUOSTIM for PGT-A
NCT06637189Phase 4Not yet recruiting
- Sponsor
- Ginefiv
- Start
- Oct 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of medroxyprogesterone acetate in infertility (2 arms), sponsored by Ginefiv. Primary endpoint: Number of Euploid Embryos up to 12 weeks. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
medroxyprogesterone acetate
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06637189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06637189.